Leta i den här bloggen


tisdag 31 december 2019

KCTD17 (22q12.3) hajoi8ttaa trikopleiinia ( keratiinia sitovaa proteiinia) . Myoklonusdystonia 26.

https://www.ncbi.nlm.nih.gov/gene/79734
Official Symbol
KCTD17
Official Full Name
potassium channel tetramerization domain containing 17
Summary
This gene encodes a protein that belongs to a conserved family of potassium channel tetramerization domain (KCTD)-containing proteins. The encoded protein functions in ciliogenesis by acting as a substrate adaptor for the cullin3-based ubiquitin-conjugating enzyme E3 ligase, and targets trichoplein, a keratin-binding protein, for degradation via polyubiquitinylation. A mutation in this gene is associated with autosomal dominant myoclonic dystonia 26. [provided by RefSeq, Nov 2016]
Expression
Broad expression in brain (RPKM 11.5), testis (RPKM 10.6) and 22 other tissues See more

     CDS             1..321
                     /gene="KCTD17"
                     /coded_by="NM_001282684.1:5..970"
                     /note="isoform 1 is encoded by transcript variant 1"
                     /db_xref="CCDS:CCDS74854.1"
                     /db_xref="GeneID:79734"
                     /db_xref="HGNC:HGNC:25705"
                     /db_xref="MIM:616386"
ORIGIN      
        1 mqtprpamrm eageaappag aggraaggwg kwvrlnvggt vflttrqtlc reqksflsrl
       61 cqgeelqsdr detgaylidr dptyfgpiln flrhgklvld kdmaeegvle eaefynigpl
      121 iriikdrmee kdytvtqvpp khvyrvlqcq eeeltqmvst msdgwrfeql vnigssynyg
      181 sedqaeflcv vskelhstpn glssessrkt ksteeqleeq qqqeeeveev eveqvqvead
      241 aqekaqssqd panlfslppl pppplpaggs rphplrpeae lavrasprpl arpqschpcc
      301 ykpeapgcea pdhlqglgvp i

Related articles in PubMed


 ( Huomaa pieniä polyproliini,  polyglutamiini ja polyglutamaattijaksoja)

KCTD16, (5q31.3) Tekee interaktion APP:n kanssa.

https://www.ncbi.nlm.nih.gov/gene/57528

Official Symbol
KCTD16 (5q31.3)
Official Full Name
potassium channel tetramerization domain containing 16
Expression
Biased expression in brain (RPKM 4.6), lung (RPKM 0.4) and 3 other tissues See more
 https://www.ncbi.nlm.nih.gov/protein/NP_001357415.1
 
ORIGIN      
        1 malsgnCsry ypreqgsavp nsfpevveln vggqvyftrH stlisipHsl lwkmfspkrd
       61 tandlakdsk grffidrdgf lfryildylr drqvvlpdHf pekgrlkrea eyfqlpdlvk
      121 lltpdeikqs pdefCHsdfe dasqgsdtri Cppssllpad rkwgfitvgy rgsCtlgreg
      181 qadakfrrvp rilvCgrisl akevfgetln esrdpdrape rytsrfylkf khlerafdml
      241 seCgfhmvaC nssvtasfin qytddkiwss yteyvfyrep srwspshCdC CCkngkgdke
      301 gesgtscndl stssCdsqse asspqetviC gpvtrqtniq tldrpikkgp vqliqqsemr
      361 rksdllrtlt sgsresnmss kkkavkekls ieeelekCiq dflkikipdr fperkhpwqs
      421 ellrkyhl
//
TB (Broad-Complex, Tramtrack and Bric a brac)/POZ (poxvirus and zinc finger) domain found in potassium channel tetramerization domain-containing protein 16 (KCTD16)
KCTD16 is a BTB/POZ domain-containing protein that is an auxiliary subunit of GABAB receptors associated with mood disorders. It interacts with amyloid beta precursor protein (APP), a type I transmembrane protein involved in a variety of cellular processes such as cell adhesion and axon guidance. The BTB/POZ domain, also known as tetramerization (T1) domain, is a versatile protein-protein interaction motif that facilitates homodimerization or heterodimerization. KCTD family BTB domains can adopt a wide range of oligomerization geometries, including homodimerization, tetramerization, and pentamerization.
Related articles in PubMed
What's a GeneRIF?

31.12. 2019. Pohdittavaa. 

måndag 30 december 2019

KCTD15 (19q13.11), Expr. skin, endometrium + 21. Neuraalipoimun induktiohierarkiassa tärkeä. Adipogeneesi. Obesitaskontrolli.

KCTD15 (19q13.119 , Expr. . skin, endometrium  +21.
https://www.ncbi.nlm.nih.gov/gene/79047

Official Symbol
KCTD15
Official Full Name
potassium channel tetramerization domain containing 15provided by HGNC
Expression
Broad expression in skin (RPKM 22.8), endometrium (RPKM 7.8) and 21 other tissues See more
Orthologs
Preferred Names
BTB/POZ domain-containing protein KCTD15
Names
potassium channel tetramerisation domain containing 15
potassium channel tetramerization domain-containing protein 15

What's a GeneRIF?
BTB/POZ domain-containing protein KCTD15 isoform 2 [Homo sapiens]
NCBI Reference Sequence: NP_001123466.1

LOCUS       NP_001123466             283 aa            linear   PRI 02-JUN-2019
DEFINITION  BTB/POZ domain-containing protein KCTD15 isoform 2 [Homo sapiens].
ACCESSION   NP_001123466
VERSION     NP_001123466.1
DBSOURCE    REFSEQ: accession NM_001129994.2
KEYWORDS    RefSeq; RefSeq Select.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 283)
  AUTHORS   Smaldone G, Pirone L, Capolupo A, Vitagliano L, Monti MC, Di
            Gaetano S and Pedone E.
  TITLE     The essential player in adipogenesis GRP78 is a novel KCTD15
            interactor
  JOURNAL   Int. J. Biol. Macromol. 115, 469-475 (2018)
   PUBMED   29665387
REFERENCE   2  (residues 1 to 283)
  AUTHORS   Gamero-Villarroel C, Gonzalez LM, Rodriguez-Lopez R, Albuquerque D,
            Carrillo JA, Garcia-Herraiz A, Flores I and Gervasini G.
  TITLE     Influence of TFAP2B and KCTD15 genetic variability on personality
            dimensions in anorexia and bulimia nervosa
  JOURNAL   Brain Behav 7 (9), e00784 (2017)
   PUBMED   28948079
  REMARK    GeneRIF: The KCTD15 rs287103 T variant allele was associated with
            increased risk of bulimia nervosa and with scores of
            psychopathological scales of these patients.
            Publication Status: Online-Only
REFERENCE   3  (residues 1 to 283)
  AUTHORS   Smaldone G, Pirone L, Pedone E, Marlovits T, Vitagliano L and
            Ciccarelli L.
  TITLE     The BTB domains of the potassium channel tetramerization domain
            proteins prevalently assume pentameric states
  JOURNAL   FEBS Lett. 590 (11), 1663-1671 (2016)
   PUBMED   27152988
REFERENCE   4  (residues 1 to 283)
  AUTHORS   Lv D, Zhang DD, Wang H, Zhang Y, Liang L, Fu JF, Xiong F, Liu GL,
            Gong CX, Luo FH, Chen SK, Li ZL and Zhu YM.
  TITLE     Genetic variations in SEC16B, MC4R, MAP2K5 and KCTD15 were
            associated with childhood obesity and interacted with dietary
            behaviors in Chinese school-age population
  JOURNAL   Gene 560 (2), 149-155 (2015)
   PUBMED   25637721
  REMARK    GeneRIF: SEC16B, MC4R, MAP2K5 and KCTD15 (rs17782313, rs543874,
            rs2241423 and rs11084753) polymorphisms are associated with the
            risk for children obesity in China.
REFERENCE   5  (residues 1 to 283)
  AUTHORS   Zarelli VE and Dawid IB.
  TITLE     The BTB-containing protein Kctd15 is SUMOylated in vivo
  JOURNAL   PLoS ONE 8 (9), e75016 (2013)
   PUBMED   24086424
  REMARK    GeneRIF: These data suggest that the non-SUMOylated form of Kctd15
            functions in neural crest development.
            Publication Status: Online-Only
REFERENCE   6  (residues 1 to 283)
  AUTHORS   Bauer F, Elbers CC, Adan RA, Loos RJ, Onland-Moret NC, Grobbee DE,
            van Vliet-Ostaptchouk JV, Wijmenga C and van der Schouw YT.
  TITLE     Obesity genes identified in genome-wide association studies are
            associated with adiposity measures and potentially with
            nutrient-specific food preference
  JOURNAL   Am. J. Clin. Nutr. 90 (4), 951-959 (2009)
   PUBMED   19692490
  REMARK    GeneRIF: Observational study of gene-disease association. (HuGE
            Navigator)
REFERENCE   7  (residues 1 to 283)
  AUTHORS   Renstrom F, Payne F, Nordstrom A, Brito EC, Rolandsson O, Hallmans
            G, Barroso I, Nordstrom P and Franks PW.
  CONSRTM   GIANT Consortium
  TITLE     Replication and extension of genome-wide association study results
            for obesity in 4923 adults from northern Sweden
  JOURNAL   Hum. Mol. Genet. 18 (8), 1489-1496 (2009)
   PUBMED   19164386
  REMARK    GeneRIF: Observational study of gene-disease association. (HuGE
            Navigator)
REFERENCE   8  (residues 1 to 283)
  AUTHORS   Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM,
            Berndt SI, Elliott AL, Jackson AU, Lamina C, Lettre G, Lim N, Lyon
            HN, McCarroll SA, Papadakis K, Qi L, Randall JC, Roccasecca RM,
            Sanna S, Scheet P, Weedon MN, Wheeler E, Zhao JH, Jacobs LC,
            Prokopenko I, Soranzo N, Tanaka T, Timpson NJ, Almgren P, Bennett
            A, Bergman RN, Bingham SA, Bonnycastle LL, Brown M, Burtt NP,
            Chines P, Coin L, Collins FS, Connell JM, Cooper C, Smith GD,
            Dennison EM, Deodhar P, Elliott P, Erdos MR, Estrada K, Evans DM,
            Gianniny L, Gieger C, Gillson CJ, Guiducci C, Hackett R, Hadley D,
            Hall AS, Havulinna AS, Hebebrand J, Hofman A, Isomaa B, Jacobs KB,
            Johnson T, Jousilahti P, Jovanovic Z, Khaw KT, Kraft P, Kuokkanen
            M, Kuusisto J, Laitinen J, Lakatta EG, Luan J, Luben RN, Mangino M,
            McArdle WL, Meitinger T, Mulas A, Munroe PB, Narisu N, Ness AR,
            Northstone K, O'Rahilly S, Purmann C, Rees MG, Ridderstrale M, Ring
            SM, Rivadeneira F, Ruokonen A, Sandhu MS, Saramies J, Scott LJ,
            Scuteri A, Silander K, Sims MA, Song K, Stephens J, Stevens S,
            Stringham HM, Tung YC, Valle TT, Van Duijn CM, Vimaleswaran KS,
            Vollenweider P, Waeber G, Wallace C, Watanabe RM, Waterworth DM,
            Watkins N, Witteman JC, Zeggini E, Zhai G, Zillikens MC, Altshuler
            D, Caulfield MJ, Chanock SJ, Farooqi IS, Ferrucci L, Guralnik JM,
            Hattersley AT, Hu FB, Jarvelin MR, Laakso M, Mooser V, Ong KK,
            Ouwehand WH, Salomaa V, Samani NJ, Spector TD, Tuomi T, Tuomilehto
            J, Uda M, Uitterlinden AG, Wareham NJ, Deloukas P, Frayling TM,
            Groop LC, Hayes RB, Hunter DJ, Mohlke KL, Peltonen L, Schlessinger
            D, Strachan DP, Wichmann HE, McCarthy MI, Boehnke M, Barroso I,
            Abecasis GR and Hirschhorn JN.
  CONSRTM   Wellcome Trust Case Control Consortium; Genetic Investigation of
            ANthropometric Traits Consortium
  TITLE     Six new loci associated with body mass index highlight a neuronal
            influence on body weight regulation
  JOURNAL   Nat. Genet. 41 (1), 25-34 (2009)
   PUBMED   19079261
  REMARK    GeneRIF: Observational study, meta-analysis, and genome-wide
            association study of gene-disease association. (HuGE Navigator)
REFERENCE   9  (residues 1 to 283)
  AUTHORS   Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V,
            Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S,
            Thorlacius S, Jonsdottir I, Jonsdottir T, Olafsdottir EJ,
            Olafsdottir GH, Jonsson T, Jonsson F, Borch-Johnsen K, Hansen T,
            Andersen G, Jorgensen T, Lauritzen T, Aben KK, Verbeek AL,
            Roeleveld N, Kampman E, Yanek LR, Becker LC, Tryggvadottir L,
            Rafnar T, Becker DM, Gulcher J, Kiemeney LA, Pedersen O, Kong A,
            Thorsteinsdottir U and Stefansson K.
  TITLE     Genome-wide association yields new sequence variants at seven loci
            that associate with measures of obesity
  JOURNAL   Nat. Genet. 41 (1), 18-24 (2009)
   PUBMED   19079260
REFERENCE   10 (residues 1 to 283)
  AUTHORS   Ballif BA, Villen J, Beausoleil SA, Schwartz D and Gygi SP.
  TITLE     Phosphoproteomic analysis of the developing mouse brain
  JOURNAL   Mol. Cell Proteomics 3 (11), 1093-1101 (2004)
   PUBMED   15345747
COMMENT     VALIDATED REFSEQ: This record has undergone validation or
            preliminary review. The reference sequence was derived from
            BP339379.1, AK027901.1, AK225793.1, AK025590.1, CX752088.1 and
            AI741557.1.
            
            Transcript Variant: This variant (2) uses a different splice site
            in the 3' coding region, compared to variant 1, that results in a
            frameshift. The resulting protein (isoform 2) has a longer and
            distinct C-terminus compared to isoform 1. Variants 2 and 3 both
            encode the same protein.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: SRR1803615.41157.1,
                                           SRR1660803.131822.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1965299, SAMEA1966682
                                           [ECO:0000348]
            ##Evidence-Data-END##
            
            ##RefSeq-Attributes-START##
            RefSeq Select criteria :: based on conservation, expression,
                                      longest protein
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..283
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="19"
                     /map="19q13.11"
     Protein         1..283
                     /product="BTB/POZ domain-containing protein KCTD15 isoform
                     2"
                     /note="BTB/POZ domain-containing protein KCTD15; potassium
                     channel tetramerisation domain containing 15; potassium
                     channel tetramerization domain-containing protein 15"
                     /calculated_mol_wt=31811
     Site            31
                     /site_type="phosphorylation"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:18669648};
                     propagated from UniProtKB/Swiss-Prot (Q96SI1.1)"
     Site            35
                     /site_type="phosphorylation"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:18669648,
                     ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:20068231,
                     ECO:0000244|PubMed:23186163}; propagated from
                     UniProtKB/Swiss-Prot (Q96SI1.1)"
     Site            38
                     /site_type="phosphorylation"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="Phosphoserine. {ECO:0000244|PubMed:18669648,
                     ECO:0000244|PubMed:20068231}; propagated from
                     UniProtKB/Swiss-Prot (Q96SI1.1)"
     Region          58..145
                     /region_name="BTB"
                     /note="BTB/POZ domain; cl02518"
                     /db_xref="CDD:321966"
     CDS             1..283
                     /gene="KCTD15"
                     /coded_by="NM_001129994.2:245..1096"
                     /note="isoform 2 is encoded by transcript variant 2"
                     /db_xref="CCDS:CCDS46039.1"
                     /db_xref="GeneID:79047"
                     /db_xref="HGNC:HGNC:23297"
                     /db_xref="MIM:615240"
ORIGIN      
        1 mphrkerpsg sslhthgstg taeggnmsrl sltrspvspl aaqgiplpaq ltksnapvhi
       61 dvgghmytss latltkypds risrlfngte pivldslkqh yfidrdgeif ryvlsflrts
      121 klllpddfkd fsllyeeary yqlqpmvrel erwqqeqeqr rrsracdclv vrvtpdlger
      181 ialsgekali eevfpetgdv mcnsvnagwn qdpthvirfp lngycrlnsv qvlerlfqrg
      241 fsvaascggg vdssqfseyv lcreerrpqp tptavrikqe pld
//

KCTD14 (11q14.19) ilmentyy lisämunuaisesa ja mahalaukussa. Kartoituksen alainen KCTD

https://www.ncbi.nlm.nih.gov/gene/65987
Official Symbol
KCTD14
Official Full Name
potassium channel tetramerization domain containing 14provided by HGNC
Expression
Broad expression in adrenal (RPKM 10.1), stomach (RPKM 9.5) and 17 other tissues See more

BTB/POZ domain-containing protein KCTD14 isoform 1 [Homo sapiens]
NCBI Reference Sequence: NP_076419.2

LOCUS       NP_076419                255 aa            linear   PRI 02-MAY-2019
DEFINITION  BTB/POZ domain-containing protein KCTD14 isoform 1 [Homo sapiens].
ACCESSION   NP_076419
VERSION     NP_076419.2
DBSOURCE    REFSEQ: accession NM_023930.4
KEYWORDS    RefSeq; MANE Select.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
           ..
REFERENCE   1  (residues 1 to 255)
  AUTHORS   Rolland T, Tasan M, et al. 
  TITLE     A proteome-scale map of the human interactome network
  JOURNAL   Cell 159 (5), 1212-1226 (2014)
   PUBMED   25416956
COMMENT     VALIDATED REFSEQ: This record has undergone validation or
            preliminary review. The reference sequence was derived from
            AP003032.2, CB993622.1, BC001929.1 and BU631809.1.
            On Apr 6, 2007 this sequence version replaced NP_076419.1.
            
            Transcript Variant: This variant (1) encodes the longer isoform
            (1).
            
            ##Evidence-Data-START##
            Transcript exon combination :: SRR3476690.88534.1,
                                           SRR3476690.497039.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA2162841 [ECO:0000348]
            ##Evidence-Data-END##
            
            ##RefSeq-Attributes-START##
            MANE Ensembl match     :: ENST00000353172.6/ ENSP00000316482.5
            RefSeq Select criteria :: based on conservation, expression,
                                      longest protein
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..255
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="11"
                     /map="11q14.1"
     Protein         1..255
                     /product="BTB/POZ domain-containing protein KCTD14 isoform
                     1"
                     /note="BTB/POZ domain-containing protein KCTD14; potassium
                     channel tetramerisation domain containing 14"
                     /calculated_mol_wt=29460
     Region          35..125
                     /region_name="BTB"
                     /note="Broad-Complex, Tramtrack and Bric a brac;
                     smart00225"
                     /db_xref="CDD:197585"
     Region          35..118
                     /region_name="BTB"
                     /note="BTB/POZ domain; cl02518"
                     /db_xref="CDD:295341"
     CDS             1..255
                     /gene="KCTD14"
                     /coded_by="NM_023930.4:28..795"
                     /note="isoform 1 is encoded by transcript variant 1"
                     /db_xref="CCDS:CCDS8255.2"
                     /db_xref="GeneID:65987"
                     /db_xref="HGNC:HGNC:23295"
ORIGIN      
        1 mwqgcaverp vgrmtsqtpl pqsprprrpt mstvvelnvg gefhtttlgt lrkfpgskla
       61 emfsslakas tdaegrffid rpstyfrpil dylrtgqvpt qhipevyrea qfyeikplvk
      121 lledmpqifg eqvsrkqfll qvpgysenle lmvrlaraea itarkssvlv clveteeqda
      181 yysevlcflq dkkmfksvvk fgpwkavldn sdlmhclemd ikaqgykvfs kfyltyptkr
      241 nefhfniysf tftww
//
Kliinistä tietoa ei  erityisemmin voi sanoa löytyvän. 


KCTD13 (16p11.2)

https://www.ncbi.nlm.nih.gov/gene/253980

Official Symbol
KCTD13
Official Full Name
potassium channel tetramerization domain containing 13provided by HGNC
Also known as
PDIP1; FKSG86; BACURD1; POLDIP1; hBACURD1
Expression
Broad expression in testis (RPKM 12.8), brain (RPKM 4.9) and 23 other tissues See more
Preferred Names
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1
Names
BTB/POZ domain-containing protein KCTD13
CTD-2574D22.4
TNFAIP1-like protein
polymerase delta-interacting protein 1; (PDIP1)
potassium channel tetramerisation domain containing 13; (KCTD13 )
https://www.ncbi.nlm.nih.gov/protein/NP_849194.1

BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 [Homo sapiens]

NCBI Reference Sequence: NP_849194.1
 
Related articles in PubMed
GeneRIFs: Gene References Into Functions
What's a GeneRIF?

söndag 29 december 2019

KCTD12(13q22.3), PFETIN, PFET1, C13orf2. ( sisältää qqqpq, pqqp sekv)

https://www.ncbi.nlm.nih.gov/gene/115207
Official Symbol
KCTD12
Official Full Name
potassium channel tetramerization domain containing 12
Also known as
PFET1; PFETIN; C13orf2
Preferred Names
BTB/POZ domain-containing protein KCTD12
Names
potassium channel tetramerisation domain containing 12
predominantly fetal expressed T1 domain
testicular tissue protein Li 100
What's a GeneRIF?

KCTD ja neurologinen ja neuropsykiatrinen kehitys Hyvä katsaus kesältä 2019

https://www.ncbi.nlm.nih.gov/pubmed/31197948
2019 Jul;25(7):887-902. doi: 10.1111/cns.13156.

KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders.

Abstract
The underlying molecular basis for neurodevelopmental or neuropsychiatric disorders is not known. In contrast, mechanistic understanding of other brain disorders including neurodegeneration has advanced considerably. Yet, these do not approach the knowledge accrued for many cancers with precision therapeutics acting on well-characterized targets. Although the identification of genes responsible for neurodevelopmental and neuropsychiatric disorders remains a major obstacle, the few causally associated genes are ripe for discovery by focusing efforts to dissect their mechanisms. Here, we make a case for delving into mechanisms of the poorly characterized human KCTD gene family.

 On erivahvuista näyttöä KCTD proteiinien osuudesta  hermoston kehityksellisiin ja nuropsykiatrisiin  häiriöihin.
KCTD3:  neurokognitiivisia häiriöitä:
KCTD7:  hermoston kehityksellisiä häiriöitä;
KCTD12:  kaksisuuntaista mielialaähäiriötä;
KCTD13  autismia ja skitsofreniaa;
KCTD11: syöpää ja
KCTD15:lihavuutta.

Varying levels of evidence support their roles in neurocognitive disorders (KCTD3), neurodevelopmental disease (KCTD7), bipolar disorder (KCTD12), autism and schizophrenia (KCTD13), movement disorders (KCTD17), cancer (KCTD11), and obesity (KCTD15). 
Collective knowledge about these genes adds enhanced value, and critical insights into potential disease mechanisms have come from unexpected sources.

KCTD11:  Ravintoineiden signaloinin vaikutus mTORC:iin-
KCTD7:  autofagia-lysosomitien vaikutus mitokondriaa.

Translation of basic research on the KCTD-related yeast protein Whi2 has revealed roles in nutrient signaling to mTORC1 (KCTD11) and an autophagy-lysosome pathway affecting mitochondria (KCTD7). 

KCTD12:
KCTD13:
KCTD 16: kalvon jonikanavan säätely eri GTP-aaseja moduloimalla

Recent biochemical and structure-based studies (KCTD12, KCTD13, KCTD16) reveal mechanisms of regulating membrane channel activities through modulation of distinct GTPases.

We explore how these seemingly varied functions may be disease related.

KEYWORDS:KCTD11; KCTD13; KCTD7; Neurodegeneration; Neurodevelopmental disorders

PMID:
31197948
PMCID:
PMC6566181
DOI:
10.1111/cns.13156

Clade Figure 2 Protein BTB structure Binding partners Biological functions Disease relevance
E KCTD17 closed pentamer (X‐ray7) Cul3 2, 32 (5:5 SAXS 5, 7) Promotes ciliogenesis by degrading trichoplein32, 106 Gen vars associated with dystonia79, 83
KCTD5 closed pentamer (EM,107 X‐ray3) Cul32 (5:5 ITC37) Inhibits GPCR signal, degrades Gβγ18; monoubiquitination of ΔNp63α108 Involved in sleep regulation86, 109
KCTD2 ND Clu329 Degrades c‐Myc29
Regulates sleep86
Low in patient‐derived glioma stem cells 29
Gen vars assoc. with Alzheimer's risk (GWAS)110, 111
KCTD9 Closed pentamer (X‐ray2) Cul3 (5:5 cryo‐EM2) ND ND
D SHKBP1 monomer (X‐ray5) Cul3 (5:5 SAXS5)
CIN85112
SETA113
Promotes EGFR pathway by disrupting c‐Cbl‐CIN85 complex112 Mutated in cervical cancer114
Mutated in leukemia115
Biomarker in small intestinal neuroendocrine tumors116
KCTD3 ND HCN391 Up‐regulation of HCN391 Biallelic mutations in epileptic encephalopathy90
Gen vars in intellectual disability/ seizures (WES)88, 89
C KCTD10 tetramer (X‐ray5) Cul331, 35, 117
PCNA6
TNFAIP1118
Degrades RhoB31, 35
Promotes cilium, degrades CEP97117
DNA synthesis, cell proliferation6
Inhibits NF‐κB and AP‐1118
Tumor suppressor in gastrointestinal stromal tumor119
TNFAIP1 ND Cul333, 76
RhoB120
PCNA8
KCTD10118
Degrades RhoA33, 76
Regulates apoptosis120
Inhibits NF‐κB and AP‐1 118
Aa a tumor suppressor in nonsmall cell lung cancer121
Poor prognosis if overexpressed in breast cancer122
Overexpressed in osteosarcoma123
KCTD13 tetra‐ (X‐ray5)
pentamer (EM107)
Cul311, 33, 76 (5:5 SAXS5) SAXS5
PCNA7
Degrades RhoA11, 33, 34, 76 Copy‐number var associated with autism11, 52, 76
Mutations associated with schizophrenia124
Overexpression: microcephaly in zebrafish, mouse34
H KCTD14 ND ND ND ND
KCTD7 ND Cul313, 36 Regulates neuronal autophagy,13 Gln transport SAT2,23 K+ conductance20 Bi‐allelic mutations cause severe early onset progressive disorder with epilepsy13, 38-41, 125
B KCTD6 pentamer (EM107) Cul32 (4:4 gel filtration16) Suppresses Hh pathway by degrading HDAC30 and USP21126
Degrades small ankyrin‐1127
ND
KCTD21 ND Cul330 Inhibits Hh by degrading HDAC30 Gen vars associated with autism (WES)128
KCTD11 tetramer (gel filtration),96
pentamer (EM107)
Cul3 (4:4 gel filtration16, 96) Inhibits mTORC1 activity14
Inhibits Hh pathway by degrading HDAC12
Deletion/ reduced expression in medulloblastoma94
Loss of heterozygosity in prostate adenocarcinoma129
Reduced expression in hepatocellular carcinoma130
Other KCTD4 ND ND ND ND
A KCTD15 pentamer (EM107) AP‐2α10 Inhibits neural crest formation by inhibiting AP‐2α10 & Wnt pathway99 Genetic variants associated with obesity97, 98
KCTD1 closed/open pentamer (EM,107 X‐ray2) AP‐2α transcription factor9 Inhibits transcription factor AP‐2α9 and Wnt signaling by degrading β‐catenin131 I27N mutation caused kidney dysfunction in mice132
Missense mutations associated with scalp‐ear‐nipple syndrome133
Other KCTD19 ND ND ND ND
F KCTD12 pentamer (EM107; X‐ray19) GABAB217
Gβγ19
CDC25B134
Regulates GABAB2 receptor signaling17, 19, 135, 136
Suppresses Wnt‐Notch pathway137
Promotes G2/M transition134
Emotionality, neuronal excitability (mice)65
KCTD12 increases 5‐y survival in GI stromal tumor138
Increased KCTD12 in cervical and lung cancers134
Bipolar disorder (GWAS)62
KCTD16 open pentamer (X‐ray5, 19) GABAB217
Gβγ19
Regulates GABAB2 receptor signaling17, 19, 135, 136 ND
KCTD8 ND GABAB217 Regulates GABAB2 signaling17, 135, 136 ND
Other KCNRG ND Kv channel139, 140 Suppresses K + channel activity139 Deleted in B‐cell chronic lymphocytic leukemia,140-142 prostate cancer140 and multiple myeloma142
Other KCTD18 ND ND ND Duplication of 2q33 in one patient with epilepsy, devel. delay, autistic behavior143
Haplotype associated with restless legs syndrome144
G KCTD20 ND ND Activates Akt145, 146 Gen var associated with insulin resistance (GWAS)147
BTBD10 ND Akt1‐3148 Inhibits apoptosis, activates Akt149, 150 Sporadic amyotrophic lateral sclerosis151
Sc Whi2 ND Psr113 Suppresses TORC1, promotes autophagy induction13 Plant pathogen CoWhi2 has suggested role in pathogenesis during infection152